Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization

Journal of Pathology

Volumn 221, Issue 1, 2010, Pages 96-105

  Uchida, Masahiro ^a,b   Tsukamoto, Yoshiyuki ^a   Uchida, Tomohisa ^a   Ishikawa, Yuta ^c   Nagai, Takayuki ^d   Hijiya, Naoki ^a   Nguyen, Lam Tung ^a,b   Nakada, Chisato ^a   Kuroda, Akiko ^a,b   Okimoto, Tadayoshi ^b   Kodama, Masaaki ^b   Murakami, Kazunari ^b   Noguchi, Tsuyoshi ^a   Matsuura, Keiko ^a   Tanigawa, Masato ^b   Seto, Masao ^e   Ito, Hisao ^f   Fujioka, Toshio ^b   Takeuchi, Ichiro ^c   Moriyama, Masatsugu ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^d Kouseiren Tsurumi Hospital   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

Author keywords

Array CGH; Gastric adenoma; Gastric carcinoma in situ; Vienna classification

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; CHROMOSOME 17P; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME 8Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GASTRIC CARCINOMA IN SITU; GENE NUMBER; GENOME; HIGH RISK POPULATION; HUMAN; INVASIVE CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOMACH ADENOMA; STOMACH CARCINOMA;

ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; STOMACH NEOPLASMS;

EID: 77951009273     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2686     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Srivastava A, Lauwers GY. Gastric epithelial dysplasia: the Western perspective. Dig Liver Dis 2008; 40: 641-649.
3. Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997; 349: 1725-1729. (Pubitemid 27252671)
4. Riddell RH, Iwafuchi M. Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable? Histopathology 1998; 33: 197-202. (Pubitemid 28430507)
5. Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol 2001; 36: 445-456. (Pubitemid 32747204)
6. Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch 2003; 442: 99-106. (Pubitemid 36337655)
7. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255. (Pubitemid 30489769)
8. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131.
9. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely a hypothesis? Best Pract Res Clin Gastroenterol 2001; 15: 983-998. (Pubitemid 34110604)
10. Di Gregorio C, Morandi P, Fante R, De Gaetani C. Gastric dysplasia. A follow-up study. Am J Gastroenterol 1993; 88: 1714-1719.
11. Saraga EP, Gardiol D, Costa J. Gastric dysplasia. A histological follow-up study. Am J Surg Pathol. 1987; 11: 788-796. (Pubitemid 17143585)
12. Rugge M, Farinati F, Di Mario F, Baffa R, Valiante F, Cardin F. Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. Hum Pathol 1991; 22: 1002-1008.
13. Kokkola A, Haapiainen R, Laxen F, Puolakkainen P, Kivilaakso E, Virtamo J, et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol 1996; 49: 979-984. (Pubitemid 27273808)
14. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology 1994; 107: 1288-1296.
15. Fertitta AM, Comin U, Terruzzi V, Minoli G, Zambelli A, Cannatelli G, et al. Clinical significance of gastric dysplasia: a multicenter follow-up study. Gastrointestinal Endoscopic Pathology Study Group. Endoscopy 1993; 25: 265-268.
16. Lansdown M, Quirke P, Dixon MF, Axon AT, Johnston D. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut 1990; 31: 977-983. (Pubitemid 20295928)
17. Rugge M, Leandro G, Farinati F, Di Mario F, Sonego F, Cassaro M, et al. Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer 1995; 76: 376-382.
18. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med 2004; 10: 789-799. (Pubitemid 39070849)
19. Davies JJ, Wilson IM, Lam WL. Array CGH technologies and their applications to cancer genomes. Chromosome Res 2005; 13: 237-248.
20. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, Tanigawa M, et al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 2008; 216: 471-482.
21. Buffart TE, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser TB, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007; 211: 45-51. (Pubitemid 46092028)
22. Gorringe KL, Boussioutas A, Bowtell DD. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2005; 42: 247-259. (Pubitemid 40171189)
23. Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet Cytogenet 2006; 167: 150-154. (Pubitemid 43792509)
24. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Stolte M, Vieth M, et al. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol 2003; 56: 293-298. (Pubitemid 37243922)
25. Buffart TE, Carvalho B, Mons T, Reis RM, Moutinho C, Silva P, et al. DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics 2007; 8: 345. (Pubitemid 350278744)
26. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
27. Yamada H, Ikegami M, Shimoda T, Takagi N, Maruyama M. Long-term follow-up study of gastric adenoma/dysplasia. Endoscopy 2004; 36: 390-396. (Pubitemid 38578884)
28. Garte SJ. The c-myc oncogene in tumor progression. Crit Rev Oncog 1993; 4: 435-449.
29. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
30. Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E, et al. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet 1998; 107: 32-36. (Pubitemid 28506743)
31. Leung SY, Ho C, Tu IP, Li R, So S, Chu KM, et al. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol 2006; 19: 854-863. (Pubitemid 43780456)
32. Tsuda H, Bandera CA, Birrer MJ, Hashiguchi Y, Berkowitz RS, Mok SC. Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology 2004; 67: 291-299. (Pubitemid 39551714)
33. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157: 787-794. (Pubitemid 32109371)
34. Cassia R, Moreno-Bueno G, Rodriguez-Perales S, Hardisson D, Cigudosa JC, Palacios J. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol 2003; 201: 589-595. (Pubitemid 38256408)
35. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347: 1566-1575. (Pubitemid 35315837)
36. Al-Aynati MM, Radulovich N, Ho J, Tsao MS. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis. Clin Cancer Res 2004; 10: 6598-6605. (Pubitemid 39346556)
37. Sutter T, Dansranjavin T, Lubinski J, Debniak T, Giannakudis J, Hoang-Vu C, et al. Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int J Colorectal Dis 2002; 17: 374-380. (Pubitemid 36075785)
38. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999; 401: 297-300. (Pubitemid 129515546)
39. Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R, et al. Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci U S A 2000; 97: 4742-4747.
40. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 1996; 215: 48-51.
41. van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, et al. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 2000; 192: 301-306.
42. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Method 1995; 57: 289-300.
43. Storey JD, Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci U S A 2003; 100: 9440-9445.
44. Ge Y, Dudoit S, Speed TP. Resampling-based multiple testing for microarray data analysis. Test 2003; 12: 1-77. (Pubitemid 36964087)